Medication-assisted treatment for opioid dependence in Twelve Step–oriented residential rehabilitation settings

Substance Abuse

Volumn 37, Issue 3, 2016, Pages 381-383

  Galanter, Marc ^a   Seppala, Marvin ^b   Klein, Audrey ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Hazelden   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANTAGONIST;

HUMAN; OPIATE ADDICTION; PROCEDURES; RESIDENTIAL CARE; SELF HELP;

HUMANS; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; RESIDENTIAL TREATMENT; SELF-HELP GROUPS;

EID: 84982227945     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2016.1187241     Document Type: Editorial

References (22)

1. World Health Organization. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020. Geneva, Switzerland:World Health Organization; 2013.
2. R.Lozano, M.Naghavi, K.Foreman, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;280:2095–2128.
3. J.C.Maxwell. The pain reliever and heroin epidemic in the United States:shifting winds in the perfect storm. J Addict Dis. 2015;34:127–140.
4. M.Botticelli. Addressing the epidemic of prescription opioid abuse and heroin use. https://www.whitehouse.gov/blog/2016/02/01/preventing-epidemic-opioid-abuse-and-heroin-use. Accessed March 1, 2014.
5. B.Han, W.M.Compton, C.M.Jones, R.Cai. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013. JAMA. 2015;314:1468–1478.
6. M.Cheatle, D.Comer, M.Wunsch, A.Skoufalos, Y.Reddy. Treating pain in addicted patients:recommendations from an expert panel. Popul Health Manag. 2014;17:79–89.
7. S.G.Mars, J.N.Fessel, P.Bourgois, F.Montero, G.Karandinos, D.Ciccarone. Heroin-related overdose:the unexplored influences of markets, marketing and source-types in the United States. Soc Sci Med. 2015;140:44–53.
8. Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373:1789–1790.
9. R.Stinchfield, P.Owen. Hazelden's model of treatment and its outcome. Addict Behav. 1998;23:669–683.
10. D.E.Jonas, H.R.Amick, C.Feitner, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings:a systemic review and meta-analysis. JAMA. 2014;311:1889–1900.
11. Bell J, Trinh L, Butler B, Randall D, Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction. 2009;104:1193–1200.
12. R.D.Weiss, J.S.Potter, D.A.Fiellin, et al. Adjunctive counseling during brief and extended buprenorphine-nalaxone treatment for prescription opioid dependence:a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011;68:1238–1246.
13. S.D.Comer, M.A.Sullivan, E.Yu, et al. Injectable, sustained-release naltrexone for the treatment of opioid dependence:a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2006;63:210–218.
14. M.Galanter, H.Dermatis, S.Post, C.Santucci. Abstinence from drugs of abuse in community-based members of Narcotics Anonymous. J Stud Alcohol Drugs. 2013;74:349–352.
15. N.D.Volkow, T.R.Frieden, P.S.Hyde, S.S.Cha. Medication-assisted therapies:tackling the opioid-overdose epidemic. N Engl J Med. 2014;370:2063–2066.
16. S.Gilman, M.Galanter, H.Dermatis. Methadone Anonymous:a 12-step program for methadone maintained heroin addicts. Subst Abus. 2001;22:247–256.
17. Monico LB, Gryczynski J, Mitchell SG, Schwartz RP, O'Grady KE, Jaffe JH. Buprenorphine treatment and 12-step meeting attendance:conflicts, compatibilities, and patient outcomes. J Subst Abuse Treat. 2015;57:89–95.
18. Project Match Research Group. Matching alcoholism treatments to client heterogeneity:Project MATCH post treatment drinking outcomes. J Stud Alcohol. 1997;58:7–29.
19. R.Moos, B.Moos, J.Andrassy. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatr Serv. 1999;50:1577–1583.
20. C.Timko, A.DeBenedetti, R.Billow. Intensive referral to 12-Step self-help groups and 6-month substance use disorder outcomes. Addiction. 2006;101:678–688.
21. B.K.Campbell, J.Guydish, T.Le, E.A.Wells, D.McCarty. The relationship of therapeutic alliance and treatment delivery fidelity with treatment retention in a multisite trial of Twelve-Step facilitation. Psychol Addict Behav. 2015;29:106–113.
22. L.A.Kaskutas, M.S.Subbaraman, J.Witbrodt, S.E.Zemore. Effectiveness of making Alcoholics Anonymous easier:a group format 12-step facilitation approach. J Subst Abuse Treat. 2009;37:228–239.